Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?
Rodriguez-Quintero JH, Jindani R, Zhu R, Loh I, Kamel MK, Montal A, Vimolratana M, Chudgar NP, Ohri N, Halmos B, Stiles BM. Rodriguez-Quintero JH, et al. Among authors: ohri n. JTO Clin Res Rep. 2024 Nov 14;6(1):100766. doi: 10.1016/j.jtocrr.2024.100766. eCollection 2025 Jan. JTO Clin Res Rep. 2024. PMID: 39758599 Free PMC article.
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial.
Dawson LA, Winter KA, Knox JJ, Zhu AX, Krishnan S, Guha C, Kachnic LA, Gillin MT, Hong TS, Craig TD, Williams TM, Hosni A, Chen E, Noonan AM, Koay EJ, Sinha R, Lock MI, Ohri N, Dorth JA, Delouya G, Swaminath A, Moughan J, Crane CH. Dawson LA, et al. Among authors: ohri n. JAMA Oncol. 2024 Dec 19. doi: 10.1001/jamaoncol.2024.5403. Online ahead of print. JAMA Oncol. 2024. PMID: 39699905
First Results of the Primary Outcome of a Phase 2 Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Patients With Breast Cancer.
Yehia ZA, Sherwani Z, Chakraborty M, Ohri N, Grann A, Eladoumikdachi F, Kowzun M, Kumar S, Potdevin L, Blackwood M, Toppmeyer D, Haffty BG. Yehia ZA, et al. Among authors: ohri n. Int J Radiat Oncol Biol Phys. 2024 Sep 4:S0360-3016(24)03320-0. doi: 10.1016/j.ijrobp.2024.08.043. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39241809
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; Study Group Investigators:. Hahn EA, et al. Among authors: ohri n. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):149-161. doi: 10.1016/j.ijrobp.2024.03.020. Epub 2024 May 13. Int J Radiat Oncol Biol Phys. 2024. PMID: 38739047 Free PMC article. Clinical Trial.
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study.
Sadoughi A, Sarkar A, Novotney C, Chan C, Moreno G, Oren S, Moss L, Aharoni K, Bari SE, Edery N, Ohri N. Sadoughi A, et al. Among authors: ohri n. Transl Lung Cancer Res. 2024 Jan 31;13(1):60-75. doi: 10.21037/tlcr-23-639. Epub 2024 Jan 29. Transl Lung Cancer Res. 2024. PMID: 38404993 Free PMC article.
190 results